Gastrointestinal Stent Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Gastrointestinal Stent Market is segmented by Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, and Pancreatic Stent), Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Gastrointestinal Stent Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Gastrointestinal Stent Market Size

Gastrointestinal Stent Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 4.90 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Gastrointestinal Stent Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Gastrointestinal Stent Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Gastrointestinal Stent Market Analysis

The Global Gastrointestinal Stent Market is expected to register a CAGR of 4.9% during the forecast period.

The COVID-19 pandemic has significantly affected the market studied as a result of restrictions on non-emergency procedures during the pandemic. According to a study published by Matthew D Rutter in July 2020, a weekly average of 35,478 endoscopy procedures were performed in the pre-COVID period. Activity in the COVID-impacted period reduced to 12% of pre-COVID levels, and at its lowest point, activity was only 5%. However, at the end of the study period, the procedures were recovering up to 20%. Similarly, according to the article published by author Amrita Sethi in August 2020, in New York, by the third week of the pandemic, the large hospital systems were 40-80% filled with COVID patients, with up to 25% requiring intensive care unit (ICU) care in some locations. On average, GI services in these hospitals decreased their procedural volume by 80 to 90%, and the consultative volume by 50%. Hence, due to the decreased number of gastrointestinal procedures during the pandemic, the growth of the market studied was hampered. However, with the pandemic in control, it is believed that the market will be gaining its pace shortly.

Furthermore, the increasing prevalence of gastrointestinal diseases coupled with aging population is contributing largely to the market growth. For instance, the Crohn's & Colitis Foundation, in 2020, estimated that two-thirds to three-quarters of those with Crohn's disease would have one or more operations in the course of their lifetime. About 30% of surgical patients would have a flare-up within 3 years, and 80% would have one within 20 years. This data indicates that in case of Crohn's disease, surgery is essential which requires GI stents. Hence, with the increasing prevalence of crohn's disease, the market studied will witness a strong growth. Additionally, according to Celiac Disease Foundation, in 2020, the prevalence of celiac disease was 0.4% in South America, 0.5% in Africa and North America, 0.6% in Asia, and 0.8% in Europe and Oceania. The prevalence was higher in female than male individuals and was significantly greater in children than in adults. In conclusion, the prevalence of celiac disease varies with sex, age, and location. Therefore, with the increasing prevalence of gastrointestinal diseases such as Celiac disease, the market studied is expected to witness strong growth over the forecast period.

Gastrointestinal Stent Industry Overview

The market for gastrointestinal stents is moderately competitive and consists of various global as well as local players. Some of the major companies operating in the market studied include Boston Scientific Corporation, CONMED Corporation, Olympus Corporation, and Cook Group Inc., among others.

Gastrointestinal Stent Market Leaders

  1. Olympus Corporation

  2. Boston Scientific Corporation

  3. Hobbs Medical Inc.

  4. Conmed Corporation

  5. Becton Dickinson and Company

  6. *Disclaimer: Major Players sorted in no particular order
Gastrointestinal Stent Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Gastrointestinal Stent Market News

  • In October 2020, Olympus launched HANAROSTENT Esophagus Through-the-Scope (TTS) Stent.

Gastrointestinal Stent Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Gastrointestinal Cancer
    • 4.2.2 Growing Geriatric Population and Age Associated GI Disorders
    • 4.2.3 Increasing Preference for Minimally-invasive Procedures
  • 4.3 Market Restraints
    • 4.3.1 High Risk of Complications
    • 4.3.2 Stringent Regulatory Environment
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size - Value in USD million)

  • 5.1 By Product Type
    • 5.1.1 Biliary Stent
    • 5.1.2 Colonic Stent
    • 5.1.3 Duodenal Stent
    • 5.1.4 Esophageal Stent
    • 5.1.5 Pancreatic Stent
  • 5.2 By Application
    • 5.2.1 Biliary Disease
    • 5.2.2 Colorectal Cancer
    • 5.2.3 Stomach Cancer
    • 5.2.4 Inflammatory Bowel Disease
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corporation
    • 6.1.2 Cook Group Inc.
    • 6.1.3 CR Bard Inc. (Becton, Dickinson, and Company)
    • 6.1.4 CONMED Corporation
    • 6.1.5 Cantel Medical Corporation
    • 6.1.6 ELLA - CS s.r.o.
    • 6.1.7 Hobbs Medical Inc.
    • 6.1.8 Merit Medical Systems Inc.
    • 6.1.9 Olympus Corporation
    • 6.1.10 Diagmed Healthcare
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Gastrointestinal Stent Industry Segmentation

As per the scope of the report, gastrointestinal stents are used for the management of obstructive symptoms in the GI tract, which can arise due to diseases of the GI tract, such as malignancies of the stomach, esophagus, duodenum, and pancreas. The Gastrointestinal Stent Market is segmented by Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, and Pancreatic Stent), Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Type Biliary Stent
Colonic Stent
Duodenal Stent
Esophageal Stent
Pancreatic Stent
By Application Biliary Disease
Colorectal Cancer
Stomach Cancer
Inflammatory Bowel Disease
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Gastrointestinal Stent Market Research FAQs

What is the current Global Gastrointestinal Stent Market size?

The Global Gastrointestinal Stent Market is projected to register a CAGR of 4.9% during the forecast period (2025-2030)

Who are the key players in Global Gastrointestinal Stent Market?

Olympus Corporation, Boston Scientific Corporation, Hobbs Medical Inc., Conmed Corporation and Becton Dickinson and Company are the major companies operating in the Global Gastrointestinal Stent Market.

Which is the fastest growing region in Global Gastrointestinal Stent Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Gastrointestinal Stent Market?

In 2025, the North America accounts for the largest market share in Global Gastrointestinal Stent Market.

What years does this Global Gastrointestinal Stent Market cover?

The report covers the Global Gastrointestinal Stent Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Gastrointestinal Stent Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Gastrointestinal Stent Industry Report

Statistics for the 2025 Global Gastrointestinal Stent market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Gastrointestinal Stent analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.